Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2020 Earnings

10AugExpected

Q3 2019

Q4 2019

Q1 2020

Q2 2020

-16.5

-11.14

-5.79

-0.43

Details

Expected EPS

-0.43

Actual EPS

-10

Surprise EPS

-9.57

Surprise Percent

+2,225.58%

Description

Spyre Therapeutics (SYRE) has reported earnings of -10 per share for Q2 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.